Genmab A Revenue per Employee (GMAB), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genmab A  (NASDAQ: GMAB)
 

Genmab A's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Genmab A's Revenue per employee fell on a trailing twelve month basis to $ 1,533,509, below the company average number of $779,765.
Within the Healthcare sector Employees of 77 other companies have achieved higher revenue per employee. While Genmab A's total ranking has deteriorated compared to the previous quarter from to 893. Genmab A has 3,029 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GMAB Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change 169.18 % - 104.42 % - 71.65 %
Sales per Employee (TTM) $ 1,533,509 761,638 1,097,259 941,267 1,046,770
GMAB's Total Ranking # 893 # # # #
Seq. Revenue Change - - - - 35.94 %

GMAB Company Profile >> Back to GMAB Efficiency Comparisons >> Compare GMAB Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 52
Healthcare Sector # 78
Overall Market # 893

Revenue per Employee Statistics
High Average Low
$ 1,228,128 $ 779,765 $ 442,052
(Dec 31 2025)   (Dec 31 2021)



Financial Statements
Genmab A's Revenue MRQ $ 3,720 Millions Visit GMAB's Income Statement
Genmab A's Revenues TTM $ 4,645 Millions Visit GMAB's aggregate revenue growth
What are GMAB's Sales? Visit GMAB's Sales by Segment




Other Ratios
Genmab A's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GMAB's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GMAB's Competitors
Revenue per Employee for GMAB's Suppliers
Revenue per Employee for GMAB's Customers

You may also want to know
GMAB's Sales Growth Rates GMAB's Pe Price to earnings ratio GMAB's Receivables Turnover Ratio GMAB's Stock Quote
GMAB's Net Income Growth Rates GMAB's Ps Price to Sales ratio GMAB's Sales per Employee GMAB's Asset Turnover Ratio
GMAB's Net Margin GMAB's Pb Price to Book ratio GMAB's Financial Strength Ratios GMAB's Dividend Payout Ratio
Date modified: 2026-07-07T11:25:19+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Spero Therapeutics Inc   2,672,080.00 $ 66.802  Million 25 
Sarepta Therapeutics Inc   2,632,619.16 $ 2,198.237  Million 835 
Grifols Sa  2,622,745.10 $ 8,426.880  Million 3,213 
Innoviva Inc   2,419,289.31 $ 384.667  Million 159 
United Therapeutics Corporation  2,273,357.14 $ 3,182.700  Million 1,400 
Anaptysbio Inc   2,255,798.08 $ 234.603  Million 104 
Assertio Holdings inc   2,239,867.92 $ 118.713  Million 53 
Aurinia Pharmaceuticals Inc   2,211,367.19 $ 283.055  Million 128 
Elite Pharmaceuticals Inc   2,131,496.71 $ 138.547  Million 65 
Exelixis Inc   2,022,777.68 $ 2,320.126  Million 1,147 
Biocryst Pharmaceuticals Inc   2,011,119.54 $ 874.837  Million 435 
Prestige Consumer Healthcare Inc   1,935,594.74 $ 1,103.289  Million 570 
Siga Technologies Inc  1,930,100.04 $ 94.575  Million 49 
Pharming Group N v   1,859,574.26 $ 375.634  Million 202 
Kiniksa Pharmaceuticals International Plc  1,851,267.76 $ 677.564  Million 366 
Collegium Pharmaceutical Inc   1,842,382.98 $ 779.328  Million 423 
Eton Pharmaceuticals Inc   1,812,272.73 $ 79.740  Million 44 
Incyte Corporation  1,807,750.35 $ 5,141.242  Million 2,844 
Ptc Therapeutics inc   1,746,372.35 $ 1,730.655  Million 991 
Zevra Therapeutics Inc   1,745,409.84 $ 106.470  Million 61 
Gilead Sciences Inc   1,731,941.18 $ 29,443.000  Million 17,000 
Privia Health Group Inc   1,731,518.76 $ 2,122.842  Million 1,226 
Rigel Pharmaceuticals Inc  1,691,275.86 $ 294.282  Million 174 
Cormedix Inc   1,590,770.76 $ 303.837  Million 191 
Tg Therapeutics Inc   1,544,578.95 $ 616.287  Million 399 
Arrowhead Pharmaceuticals Inc   1,534,431.79 $ 1,090.981  Million 711 
Progyny Inc   1,505,238.32 $ 1,288.484  Million 856 
Novavax inc   1,499,971.96 $ 1,123.479  Million 749 
Xenetic Biosciences Inc   1,488,205.50 $ 2.976  Million 2 
Alnylam Pharmaceuticals Inc   1,485,574.80 $ 3,713.937  Million 2,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.